Effect of 4 years of seasonal malaria chemoprevention on the acquisition of antibodies to Plasmodium falciparum antigens in Ouelessebougou, Mali

BACKGROUND: More than 200 million people live in areas of highly seasonal malaria transmission where Seasonal Malaria Chemoprevention (SMC) with sulfadoxine-pyrimethamine (SP) and amodiaquine (AQ) was recommended in 2012 by WHO. This strategy is now implemented widely and protected more than 19 mill...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahamar, Almahamoudou, Issiaka, Djibrilla, Youssouf, Ahamadou, Niambele, Sidi M., Soumare, Harouna M., Attaher, Oumar, Barry, Amadou, Narum, David L., Duffy, Patrick E., Greenwood, Brian, Fried, Michal, Dicko, Alassane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788529/
https://www.ncbi.nlm.nih.gov/pubmed/33413417
http://dx.doi.org/10.1186/s12936-020-03542-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788529/
https://www.ncbi.nlm.nih.gov/pubmed/33413417
http://dx.doi.org/10.1186/s12936-020-03542-9

Ejemplares similares